Ads
related to: acute myeloid leukemia news- Efficacy Data
Studied against the best available
therapies for myelofibrosis
- Dosing & Administration
Learn about dosing and
administration now
- Efficacy Data
Search results
Syrian first lady Asma Assad diagnosed with leukemia, president’s office says - WTOP News
WTOP Washington· 25 minutes agoSyrian first lady Asma Assad has been diagnosed with leukemia, the office of President Bashar Assad announced Tuesday. The president’s wife was diagnosed with acute ...
Actinium Announces Oral Presentation Detailing Improved Survival Outcomes in TP53 Positive Patients...
WJTV Jackson· 6 days agoThe Phase 3 SIERRA trial enrolled 153 patients ages 55 and above with active relapsed or refractory acute myeloid leukemia (r/r AML) ...
Patients Over 80 Still Benefit From Treatment for AML Blood Cancer
Alaska Superstation· 7 days agoSeniors over 80 with acute myeloid leukemia can safely and effectively take the standard targeted...
Ryvu Therapeutics First Quarter 2024 Financial Results and Corporate Update
FOX 59 Indianapolis· 6 days agoAs of May 9, 2024, Ryvu's cash position was $59.0M, inclusive of the first tranche of €8M in venture...
Earnings call: Aptose Biosciences targets AML treatment with tuspetinib By Investing.com
Investing.com· 6 days agoAptose Biosciences (NASDAQ:APTO) has focused its efforts on developing tuspetinib as part of a novel...
ABC6 'Runs for Brayden' at Rhode Island Half Marathon | ABC6
ABC 6 Providence· 2 days agoEAST PROVIDENCE, R.I. (WLNE) — Members of the ABC6 News staff and more than a thousand others laced...
$725M Verdict Against ExxonMobil in Landmark Benzene Cancer Case
WKRN Nashville· 6 days agoAndrew DuPont of Locks Law Firm, obtained a verdict of $725.5M against ExxonMobil on behalf of Paul Gill and his wife Diane Gill in a benzene case in the Philadelphia Court of Common Pleas.
Ryvu Therapeutics to present clinical and preclinical data on RVU120 at the 2024 European Hematology...
FOX 23 News Albany· 7 days agoUpdated data from the Phase I trial of RVU120 in patients with relapsed/refractory acute myeloid ...
StockNews.com Upgrades Syros Pharmaceuticals (NASDAQ:SYRS) to Hold
ETF DAILY NEWS· 4 days agoSyros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a report released on Wednesday. Several other equities ...
Celularity Inc. (NASDAQ:CELUW) Short Interest Up 34.4% in April
ETF DAILY NEWS· 6 days agoCelularity Inc. (NASDAQ:CELUW – Get Free Report) was the recipient of a significant increase in short interest in the month of April. As of April 30th, there was short interest totalling 161,700 ...
Ads
related to: acute myeloid leukemia news